NHLBI Announces Two New Funding Opportunities

The National Heart, Lung, and Blood Institute (NHLBI) has recently released two new Funding Opportunity Announcements (FOAs): Catalyzing Innovation in Late Phase Clinical Trial Design. The purpose of these FOAs is to provide support for planning activities for late phase (phase II and beyond) single-site or multi-site investigator-initiated clinical trials that address critical clinical questions within the mission of the NHLBI and that require non-traditional clinical trial designs with the opportunity for statistical novelty and/or innovation. 
To apply, click on the FOA and complete the form: 
Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans (U34 Clinical Trial Not Allowed)
Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans Resource Access (X01 Clinical Trial Not Allowed)
Deadlines to Submit Applications for each are: July 19, 2018, and October 19, 2018

---